Rayonier Advanced Materials (RYAM) Stifel 2024 Cross Sector Insight Conference summary
Event summary combining transcript, slides, and related documents.
Stifel 2024 Cross Sector Insight Conference summary
1 Feb, 2026Company overview and market position
Leading global producer of dissolving wood pulp (high purity cellulose) with unique supply redundancy through multiple production lines.
Largest global supplier of high purity cellulose specialties, operating four facilities in the U.S., Canada, and France.
Operates in specialty cellulose, paperboard, and high-yield pulp, with non-core assets positioned as cash generators or for sale.
Captured significant stranded demand and pricing power after a competitor's plant closure, becoming sole supplier in several markets.
Products serve diverse end markets, including food, pharmaceuticals, industrials, and packaging.
Strategic initiatives and operational changes
Actively reducing exposure to commodity cellulose by shifting production to higher-margin specialty products and operating assets only when profitable.
Closed the Temiskaming HPC line to eliminate negative EBITDA, expecting $15–$20 million annual EBITDA and free cash flow benefit.
Selling non-core paperboard and high-yield pulp businesses to focus on core operations and pay down debt, with process expected to complete in 2024.
Asset optimization includes monetizing passive assets and working capital from plant closures.
Cost savings initiatives, automation, and plant efficiencies targeted to enhance margins.
Financial performance and outlook
2023 revenue was $1.6 billion, with EBITDA guidance rising from $139 million in 2023 to $180–$200 million in 2024.
EBITDA margin expected to increase from 9% to nearly 12% by year-end, driven by improved sales mix and competitor exit.
Free cash flow projected at $80–$100 million for 2024, with net leverage targeted below 2.5x by 2027.
Committed to paying down $70 million in debt in 2024, aided by asset sales and tax refunds.
Stable core cellulose specialties business expected to drive EBITDA to $325 million by 2027, with biomaterials contributing $42 million annually.
Latest events from Rayonier Advanced Materials
- Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with debt reduction and margin expansion in focus.RYAM
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 net sales and earnings surged, with 2024 guidance raised and cash flow outlook improved.RYAM
Q2 20242 Feb 2026 - Q3 net sales and Adjusted EBITDA surged, 2024 guidance held, and $700M refinancing secured.RYAM
Q3 202416 Jan 2026 - Focus on specialty cellulose, biomaterials, and debt reduction drives margin and cash flow growth.RYAM
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025